Cargando…
COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach
BACKGROUND: The novel Coronavirus SARS-CoV-2, which was identified after a recent outbreak in Wuhan, China, in December 2019, has generated a global pandemic impacting over 200 countries around the world. Recent reports suggest that ACE2, which is the target protein to invade the host, has a ubiquit...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191299/ https://www.ncbi.nlm.nih.gov/pubmed/32388451 http://dx.doi.org/10.1016/j.msard.2020.102165 |